InvestorsHub Logo
Followers 7
Posts 301
Boards Moderated 0
Alias Born 03/31/2016

Re: None

Tuesday, 05/09/2023 7:31:13 AM

Tuesday, May 09, 2023 7:31:13 AM

Post# of 461820
Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results

https://www.anavex.com/post/anavex-life-sciences-reports-fiscal-2023-second-quarter-financial-results


Newly available preliminary efficacy results of surrogate biomarkers from the ANAVEX®2-73-AD-004 study; allowing initiation of discussions with regulatory agencies for Accelerated Approval Pathway for ANAVEX®2-73 (blarcamesine) in Alzheimer’s disease with convenient oral treatment

On track to release top-line data of potentially pivotal ANAVEX®2-73-RS-003 Phase 2/3 EXCELLENCE pediatric clinical trial in the second half of 2023
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News